| Limited inhibition of multiple nodes in a driver network blocks metastasis AE Yesilkanal, D Yang, A Valdespino, P Tiwari, AU Sabino, LC Nguyen, ... Elife 10, e59696, 2021 | 24 | 2021 |
| Immunometabolic coevolution defines unique microenvironmental niches in ccRCC C Tang, AX Xie, EM Liu, F Kuo, M Kim, RG DiNatale, M Golkaram, ... Cell Metabolism 35 (8), 1424-1440. e5, 2023 | 8 | 2023 |
| Sample Site Impacts RNA Biomarkers for Renal Cell Carcinoma L Eismann, AX Xie, C Tang, A Knezevic, I Ostrovnaya, F Kuo, AA Hakimi, ... European Urology, 2024 | 1 | 2024 |
| Functional and translational consequences of immunometabolic coevolution in ccRCC. E Reznik, C Tang, A Xie, EM Liu, F Kuo, M Kim, M Golkaram, Y Chen, ... Oncologist 28, 2023 | 1 | 2023 |
| Prognostic factors for survival in patients undergoing surveillance after cytoreductive nephrectomy SW Reese, S Khaleel, A Silagy, A Xie, L Eismann, K Vazquez-Rivera, ... Journal of Urology 210 (2), 273-279, 2023 | 1 | 2023 |
| Joint probabilistic modeling of multimodal metabolic data with UnitedMet AX Xie, C Bradshaw, C Tosh, W Tansey, E Reznik Cancer Research 84 (6_Supplement), 3512-3512, 2024 | | 2024 |
| UnitedMet harnesses RNA-metabolite covariation to impute metabolite levels in clinical samples AX Xie, W Tansey, E Reznik medRxiv, 2024.05. 24.24307903, 2024 | | 2024 |
| MP04-10 MACHINE LEARNING PREDICTS METABOLIC BIOMARKERS OF RESPONSE TO ANTI-VEGF DRUG SUNITINIB IN CCRCC K Vazquez-Rivera, XA Xie, S Reese, R Kotecha, M Voss, R Motzer, ... Journal of Urology 209 (Supplement 4), e37, 2023 | | 2023 |
| Abstract C016: Genomic analysis of patients across continental ancestry groups J Carrot-Zhang, J New, A Xie, G Frampton Cancer Epidemiology, Biomarkers & Prevention 32 (1_Supplement), C016-C016, 2023 | | 2023 |
| Type 1 interferon remodels normal and neoplastic hematopoiesis in human C Lama, S Rosenberg, A Kubas-Meyer, XA Xie, S Moein, N Parghi, ... bioRxiv, 2022.09. 28.509751, 2022 | | 2022 |
